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Summary
The Ser/Thr kinaseMARK2 phosphorylates tau protein
at sites that cause detachment from microtubules in
Alzheimer neurofibrillary degeneration. Homologs of
MARK2 include Par-1 in C. elegans and Drosophila,
which generates embryonic polarity. We report the
X-ray structure of the catalytic and ubiquitin-associated
domains (UBA) of human MARK2. The activity was al-
tered by mutations in the ATP binding site and/or acti-
vation loop. The catalytic domain shows the small and
large lobes typical of kinases. The substrate cleft is in
an inactive, open conformation in the inactivated and
the wild-type structure. The UBA domain is attached
via a taut linker to the large lobe of the kinase domain
and leans against a hydrophobic patch on the small
lobe. The UBA structure is unusual because the orien-
tation of its third helix is inverted, relative to previous
structures. Possible implications of the structure for
the regulation of kinase activity are discussed.
Introduction
The activity of the protein kinase MARK (MAP microtu-
bule affinity regulating kinase) was initially noticed in
the search for pathological phosphorylation sites of
tau protein (Biernat et al., 1993). Tau is a microtubule-
associated protein prominent in the brain, particularly
in the axonal compartment of neurons, where it helps
to stabilize microtubules. The tau-microtubule interac-
tion is regulated by phosphorylation, especially at the
KXGS motifs in the repeat domain of tau which repre-
sents the core of the microtubule binding domain. The
same domain also forms the core of the abnormal tau
aggregates (paired helical filaments; PHF) in Alzheimer’s
disease. Microtubule binding and PHF assembly are ef-
ficiently suppressed when tau is phosphorylated by
MARK. Thus, excess activation of MARK in cells leads
to microtubule breakdown because they are not prop-
erly stabilized. A second function of tau is its interfer-
ence with motor proteins moving along microtubules;
this function is also fine-tuned in axons by MARK (Man-
delkow et al., 2004). Both MARK and tau are important
for the establishment of neuronal polarity (Biernat
et al., 2002).
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(w720–790 amino acids) which contains an N-terminal
leader sequence, a kinase catalytic domain, a ubiq-
uitin-associated domain (UBA), a spacer, and a tail do-
main containing the KA1 (kinase-associated) motif char-
acteristic for the family of kinases ending with the ELKL
motif (Figure 1A). Four isoforms of MARK (1–4) were
found in rats, encoded by different genes, with addi-
tional splicing variants (Drewes, 2004; Drewes et al.,
1997). MARK family members show a striking homology
to kinases of the Par-1 family, which are best known for
their role in defining embryonic polarity in Drosophila
and C. elegans (for reviews, see Kemphues, 2000; Tom-
ancak et al., 2000). Members of the MARK/Par-1 family
occur in most organisms examined so far. Analysis of
the human genome showed that there are four members
of the human MARK family which belong to the class of
CaMKII kinases (Manning et al., 2002). Known targets of
MARK family members include tau, MAP2, MAP4, dou-
blecortin, PTPH1, Cdc25C, KSR1, plakophilin, dishev-
elled, oskar, and Raf1; these proteins are typically in-
volved in the regulation of the cytoskeleton and in
signaling (for a review, see Drewes, 2004).
Like other kinases, MARK family members can be ac-
tivated by phosphorylation in the ‘‘activation loop’’
which controls the access of the substrate to the cata-
lytic center (for reviews, see Huse and Kuriyan, 2002).
This can be achieved by the protein kinase MARKK,
which phosphorylates T208 in MARK2 and the corre-
sponding residues in MARK1, 3, and 4 (Timm et al.,
2003). The same kinase was found in the context of ac-
tivation of MEKs and named TAO-1 (Hutchison et al.,
1998). MARK can also be activated by LKB1, which
plays a role in tumor suppression (Lizcano et al., 2004).
A notable feature of MARK isolated from brain tissue is
its double phosphorylation in the activation loop (at
T208 and S212 in MARK2) (Drewes et al., 1997). Whereas
phosphorylation of T208, the target of MARKK or LKB1,
activates the kinase, phosphorylation of S212 is inhibi-
tory (Timm et al., 2003). A further level of regulation lies
in the association with other proteins and domains. In
the related kinase KIN1 in yeast, the tail domain motif
is thought to bind and inactivate the catalytic domain
(Elbert et al., 2005). MARK in turn phosphorylates other
partners which then bind to 14-3-3, such as Cdc25C,
KSR1, plakophilin, or Raf-1 (Benton et al., 2002; Muller
et al., 2003). Finally, the presence of a UBA domain
adjacent to the catalytic domain suggests potential in-
teractions with proteins involved in the ubiquitin proteo-
some pathway, DNA repair, or cell signaling (Brajenovic
et al., 2004; Hofmann and Bucher, 1996; Mueller and
Feigon, 2002).
Because of the potential importance of MARK in basic
physiological processes and human pathology, we em-
barked on a structural analysis of MARK family mem-
bers as a step toward identifying interaction sites or in-
hibitors. Here we report the X-ray structure of the
catalytic domain of MARK2, combined with the UBA do-
main. The catalytic domain shows the typical features
expected for an inactive kinase with a disordered
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(A) Bar diagram of MARK2 domain structure. Residue numbers refer to the longest isoform of human MARK2 (Swiss-Prot entry Q7KZI7). Phos-
phorylation of T596 by atypical PKC downregulates membrane localization and kinase activity (Hurov et al., 2004). The short bar diagram above
that of the full-length protein represents the construct used for X-ray structure analysis. The fragment used is identical in rat and human MARK2.
(B) Structural sequence comparison of MARK2 and related kinases. Secondary structure is color coded (orange, a helices; pink, 310 helices;
yellow, b strands) and numbered in the usual kinase convention. Special elements are boxed (P-loop in active site, hinge between lobes, catalytic
loop containing RD motif, activation segment with N anchor, P+1 loop, and C anchor, CD domain, UBA domain). Blue residues are not visible due
to disorder.
(C) Kinase activities of the MARK2 constructs. Relative activities were assayed as described (Drewes et al., 1997) using a substrate peptide from
the first repeat of tau containing S262 in the KXGS motif (TR1 peptide NVKSKIGSTENLK); data show averages of four experiments (error bars,
SEM).activation loop. The UBA domain is tethered to the large
lobe via an extended linker comprising a structural motif
similar to the common docking domain of the MAPK
family that provides an interaction site for upstream or
downstream signaling molecules.
Results
The fragment of human MARK2 described here (resi-
dues N39–K364) comprises part of the N-terminal
header (N39–N52), catalytic domain (Y53–M304), CD
motif and linker (N305–D322), and UBA domain (Y323–
K362) (Figures 1A and 1B). Crystals of the wild-type con-
struct and of two inactive mutants were analyzed, K82R
and T208A/S212A. K82 is essential for catalysis, T208 is
the primary phosphorylation site in the activation loop,
and S212 was also found to be phosphorylated in
MARK2 from brain (Drewes et al., 1997). Phosphoryla-tion of T208 is required for full activation, but phosphor-
ylation of S212 or mutation to alanine completely abol-
ishes the kinase activity of MARK2 (Timm et al., 2003).
Many Ser/Thr kinases have a conserved threonine at po-
sition S212 in MARK2 which contributes to substrate
specificity and assists in catalysis (Chen et al., 2000;
Min et al., 2004; Taylor et al., 1995). Figure 1C shows
that the wild-type construct has a basal kinase activity
even without phosphorylation of T208, whereas the ac-
tivities of the mutants are largely diminished. The three
variants and a selenomethionine (SeMet) derivative of
the T208A/S212A double mutant crystallized in the hex-
agonal space group P61. Two similar crystal forms were
observed, which differ only by the length of the c axis:
c = 106.0 A˚ for the double mutant, and c = 99.7 A˚ for the
wild-type and the K82R mutant; the wild-type was found
in both forms. All crystal structures are similar in crys-
tal packing and folding of the molecules. The general
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Domains of MARK2
Stereoview of an overlay of Ca traces of mol-
ecules A and B in the asymmetric unit, based
on the SeMet double mutant T280A/S212A
(A, blue; B, with different colors depending
on distance to A, blue to red). The superposi-
tion was calculated using residues 135–309
(C lobe). Not shown are residues 38–47, 193–
205 (activation loop, indicated by dashed
line), and 363–364. Besides the initial resi-
dues (48–51), the largest shift in Ca positions
occurs in the UBA domain (maximum 1.87 A˚
at residue M335).
Figures 2 and 4–7 were prepared with Deep
View Swiss-PDB Viewer (Guex and Peitsch,
1997) and POVray for Windows (Persistence
of Vision Pty. Ltd.; Persistence of Vision Ray-
tracer Version 3.5, retrieved from http://www.
povray.org/).structure will be described by reference to the T208A/
S212A mutant, which has the highest resolution.
Catalytic Domain
The crystals contain two molecules per asymmetric unit
(Ca traces; Figure 2). The kinase domain has a bilobed
structure like many other kinases. The smaller, N-termi-
nal lobe (residues w53–130; N lobe) consists of five
b strands and an a helix (helix C according to cAMP-
dependent protein kinase; PKA), whereas the C-terminal
lobe (residues w135–304; C lobe) is composed mainlyof a helices. A structural sequence alignment with other
kinases is presented in Figure 1B, including the notation
used for the structural elements. The 11 initial residues
(G38–P48) are invisible due to disorder. Residues
D193–K205 including the DFG motif and most of the
activation loop are also disordered. Figure 3A shows
details of the electron density map around L206, the
first residue following the invisible part of the activation
segment. The two lobes are linked by a flexible segment
of six amino acids (130–135) including two glycines,
G134–G135. Furthermore, H bonds between the lobesFigure 3. Electron Density Maps of the SeMet
T208A/S212A Double Mutant
Wire frame representation (stereoview) of
weighted 2Fo 2 Fc maps calculated with
REFMAC5 (Murshudov et al., 1997) and con-
toured at 1s level. The final model is superim-
posed to the electron density.
(A) View of the C-terminal end of the activa-
tion segment. Residues L206–S212A were
omitted before calculation of the map. The
view is perpendicular to the 2-fold NCS axis
relating molecules A and B. Close to the cen-
ter are cysteines C210 of both molecules,
which form a disulfide bridge (orange) in the
structures of the MARK2 double mutant.
(B) View of the C-terminal part of the peptide
stretch that links the UBA domain to the cat-
alytic domain. Residues Y316–K324 were
omitted before calculation of the map. Al-
though there is virtually no contact to the cat-
alytic domain or to another molecule, the
electron density is well defined. The figure
was generated with PyMOL (DeLano, 2002).
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(A and D) MARK2 double mutant; (B and E) inactive Aurora-A (PDB code 1MUO); and (C and F) Aurora-A in the fully activated state (PDB code
1OL5) with a fragment of the activating protein TPX2 (gray). In all panels, the catalytic loop is red and the activation segment is purple. Catalyt-
ically important residues are shown in stick model representation. All three structures are in the same orientation by least-squares superposition
of their catalytic loops (residues 171–183 in MARK2, 252–264 in Aurora-A).
(A–C) Front view, showing the open ([A and B], inactive state) or closed ([C], active state) cleft between the lobes. In the active state (C), the ac-
tivation loop is ordered and points to the right side; in the inactive state, it is disordered and presumably leans to the left side. In (A) and (B),
plausible conformations of the invisible part of the activation loop are indicated by dotted lines.
(D–F) Side view, showing a close-up of the nucleotide binding site with catalytic loop and helix C; the P-loop has been omitted to allow an un-
obstructed view of the invariant ion pair (K82 and E100 in MARK2, K162 and E181 in Aurora-A) that coordinates a- and b-phosphates of the bound
nucleotide in the active state (F). In the inactive structures (D and E), the ion pair interaction is disrupted. Part of the catalytic loop around the
enzymatically active aspartate (D175 in MARK2, D256 in Aurora-A) and the preceding arginine (R174 in MARK2, R255 in Aurora-A) is represented
by its Ca trace to show the subtle differences in the conformations of MARK2 and Aurora-A. In the active state (C and F), the arginine of the con-
served RD motif is hydrogen bonded to phosphothreonine pT288.connect residues in the loop between helix C and strand
b4 (C lobe) with residues in helix E and the loop between
b7 and b8 (N lobe). Both the covalent link and the H bond
interactions are restricted to a narrow region at the back
of the catalytic cleft and serve as a hinge that allows the
small lobe to librate, thereby opening and closing the
catalytic cleft.
Conformation of the Activation Loop
Whereas most of the activation loop is disordered in the
wild-type and K82R structures (D193–C210), the T208A/
S212A mutant reveals five more residues at the end of
the activation loop (L206–C210). This includes the P+1
loop (F209–A217), which is thought to recognize the
substrate by specific interaction with the residue follow-
ing the phosphorylation site. The end of the activation
segment (P213–E219 including the APE motif) is well
defined in all MARK2 structures. The conformation of
the structured parts of the activation segment indi-
cates that it folds away from helix C, in the opposite di-
rection to most active kinases (Nolen et al., 2004), and
occupies the area below the P-loop (Figure 4; see
Discussion).Intermolecular Disulfide Bridge
In the double mutant, the end of the activation loop (206–
212) is stabilized by an intermolecular disulfide bridge
between cysteines C210 of two adjacent molecules
that are related by noncrystallographic symmetry (Fig-
ure 3A). C210 is located in the midst of T208A and
S212A, the two phosphorylatable sites that distinguish
the double mutant from the wild-type. Formation of the
disulfide bridge is probably a crystallization artifact. It
appears that the S-S bridge is essential for crystalliza-
tion, as crystals do not form in the presence of dithio-
threitol (DTT). This holds for all variants of the protein, al-
though the disulfide bridge is visible only in the T208A/
S212A structure.
Dimerization
The MARK2 crystals contain two molecules per asym-
metric unit (A and B) that interact via multiple contacts
and form a dimer with a proper 2-fold noncrystallo-
graphic symmetry (Figure 5). The catalytic domains in a
dimer face each other with their active sites. The most
variable and disordered portion of the activation seg-
ment is close to the center of the dimer, encircled by
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177Figure 5. Intermolecular Contacts in MARK2
Dimers
Ribbon diagram (stereoview) of the wild-type
dimer viewed along the noncrystallographic
2-fold symmetry axis (molecule A, blue; B,
purple). Residues involved in intermolecular
contacts (at least one atom closer than 4 A˚
to an atom of the other molecule) are shown
in stick model representation. Contact resi-
dues are color coded according to their dis-
tance from cyan (4 A˚) to red (w2 A˚). The short-
est contact (2.07 A˚ distance) is between
cysteines C210 in the double mutant (see
Figure S2) which form an interchain disulfide
bridge. No disulfide bridge is observed in the
wild-type structure due to disorder. Most of
the contact residues are in two zones: C-ter-
minal anchor of the activation loop and the
following loop preceding helix F (zone 1, res-
idues 206–227) and helix G and part of its
N-terminal loop (zone 2, residues 251–261).
In the double mutant (not shown; see Fig-
ure S2), zone 1 comprises 15 contact resi-
dues in the range from D207 to D227, zone 2
all but one residue in the range D251–R261.
For the wild-type the corresponding numbers
are lower (nine residues in zone 1, five residues in zone 2), due to disordered residues L206–C210. Residues S92, S93, and K96 at the N terminus
of helix C form another cluster of contact residues (zone 3). Helix G and the preceding loop (zone 2) in one molecule insert into the space between
zones 1 and 3 of the other molecule, making extensive contacts with both of these zones and approaching the RD motif (R174, D175) in the cat-
alytic loop.the four lobes of the catalytic domains. Interactions be-
tween the monomers are concentrated in three zones
(Figure 5). Zone 1 in the C lobe and zone 3 in the N lobe
of one molecule form a wide-open entrance to the cata-
lytic cleft. Helix G of the other molecule (zone 2) inserts
into this space, making contacts to both rims. In the
T208A/S212A mutant, 30 residues of each molecule are
involved in intradimer contacts, whereas the wild-type
and K82R mutant show only 18 contact residues, and
the S-S bond at C210 is not visible. Thus, the dimer-form-
ing interaction in these constructs appears to be weak-
ened compared to the double mutant. This could explain
the difference in crystal packing between wild-type and
double mutants (see Supplemental Data available with
this article online).
UBA Domain
The UBA domain (Y323–K362) is a small, globular do-
main that consists of three short helices (a1–a3). Helices
a1 and a3 are roughly antiparallel (folding reminiscent of
a ‘‘U’’; Figure 6). This conformation is unexpected be-
cause the helices of other UBA domains solved so far
(Figure 6A; structural sequence alignment) alternate so
that a1 and a3 are almost parallel to each other (as in
an ‘‘N’’). Figure 6B compares stereoviews of the MARK2
UBA domain (yellow) with the UBA domain of HHR23A
(green) (Protein Data Bank [PDB] code 1IFY [Mueller
and Feigon, 2002]), which is representative of the other
UBA domains listed in Figure 6A.
In MARK2, the UBA domain binds to the N lobe of the
catalytic domain close to the hinge, opposite to the cleft
(i.e., at the ‘‘back side’’). The interaction is predomi-
nantly hydrophobic and mainly due to helix a3 (see Fig-
ures 6A and 6C). At the catalytic domain, the interaction
involves residues L115 and F116 at the beginning of b4.
Other hydrophobic interactions involve residues at the
N terminus of the N lobe (Y53) and at the b2-b3 turn;for example, L74 interacts with M335 and Y337 between
helices a1 and a2 of the UBA domain which belong to the
MGF/Y motif characteristic for UBA domains. In addition
to the hydrophobic interactions, residue K105 at the end
of helix C and the side chain amino group of K114 form
hydrogen bonds to Y351 in the UBA domain.
Most UBA domains contain one or two leucines near
the end of a3 (three in the case of MARK2, L359–L361).
The first one (corresponding to L359) is highly con-
served. It is important for the internal cohesion of the
UBA domain by fitting into a hydrophobic pocket formed
by residues of a1-a2 and the MGF/Y motif. In MARK2,
the conserved L359 lies on the outside of the reversed
helix a3 and makes hydrophobic contacts with the N
lobe of the catalytic domain. Instead of L359, L361 forms
hydrophobic intra-UBA interactions with side chains of
helix a1 and the MGF/Y motif. The hydrophobic pocket
normally occupied by the conserved leucine is narrowed
by a w30º inward tilt of Y337. The remaining space is
filled with the side chain of V354 at the start of a3
which—because of the inversion of the helix—ends up
roughly at the same place as the conserved leucine in
normal UBA structures.
In the position observed here, the UBA domain would
not be able to interact with ubiquitin, judging by the pub-
lished structures of mono- or polyubiquitin docked onto
UBA domains of other proteins (Ohno et al., 2005; Vara-
dan et al., 2005). There would be a steric clash with the N
lobe (Figure 6D). Consistent with this, attempts to iden-
tify a MARK2-ubiquitin complex biochemically have
failed so far (data not shown).
UBA Linker and Common Docking Domain
for Kinase Activators
The UBA domain is linked to the catalytic domain by
w20 residues (w305–322; Figures 2 and 7). The first
half contains a motif similar to the common docking
Structure
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(A) Structural sequence alignment of UBA domains. Parts of the sequences determined by NMR or X-ray analysis are highlighted by gray and
colored background (orange for helices a1, a2, and a3, pink for other helices; boundaries determined with PROMOTIF [Hutchinson and Thornton,
1996]). Leading or trailing residues on white background were not part of the constructs. The parts enclosed by the black line correspond to the
UBA domain identified by Prosite scans (Release 19.2 [Bucher and Bairoch, 1994]). Residues at the C terminus of MARK2 are printed in purple to
indicate that the structural alignment breaks down for this part of the sequence: starting with R350, the polypeptide chain diverges from the com-
mon trace of the other UBA structures, resulting in an orientation of the final helix that is reversed compared to normal UBA domains. Residues
that have been shown to interact with ubiquitin are marked by blue underlines (for HHR23A, PDB code 1DVO; only residues of the primary in-
teraction site are highlighted). In the case of MARK2, residues in contact with the N lobe of the kinase domain are marked. Columns: source,
protein name, domain, Prosite score, PDB code. A plus sign following the Prosite score indicates that binding to ubiquitin has been reported.
The list is sorted according to the Prosite score; sequences at the end of the list are not recognized as UBA domains (no score), although
they are structurally similar.
(B) Stereoview: overlay of the MARK2 UBA domain (yellow) with that of HHR23A (green) (PDB code 1IFY [Mueller and Feigon, 2002]) after least-
squares superposition of nine residues in helix a1. Residues M335 and Y337 of the MGY motif are shown in stick model representation. Helix a2 of
MARK2 is tilted outward by about 20º compared to HHR23A. This is accompanied by a change in the main chain conformation of the MGY loop
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179motif (CD) of MAP kinases, characterized by a cluster of
negative surface charges (DxxD/E; Tanoue et al., 2000).
In MARK2, the motif E309DDE312 and surrounding resi-
dues fold into a loop similar to the common docking do-
main (CD domain) of MAP kinases (Figure 7). Together
with the ED site (corresponding to residues A185–D186
in MARK2) at the tip of the b7-b8 turn, the CD domain
is thought to form a docking groove for upstream and
downstream signaling molecules on the back surface
of the catalytic domain opposite the active site (Tanoue
and Nishida, 2003), although the exact location of the
docking groove is still a matter of debate (Chang et al.,
2002). The presence of these features in MARK2 sug-
gests a similar function, but the putative docking part-
ners are not known so far.
Figure 7. Common Docking Domain and ED Site of MAP Kinases
Compared to MARK2
The structures of (A) MARK2 and (B) ERK2 (PDB code 2ERK [Cana-
garajah et al., 1997]) are shown in the same orientations after least-
squares superposition of 35 residues from helix E to the catalytic
loop. The common docking domain (CD, in red) according to Tanoue
and Nishida (2003) is C terminal to the kinase domain and corre-
sponds in MARK to the first half of the tether connecting the kinase
domain to the UBA domain (residuesw305–315). The C-terminal ex-
tensions following the CD domain (linker and UBA domain in
MARK2) are shown in purple. Characteristic for the CD domain is
a cluster of negatively charged residues exposed to the surface,
located in a bulge at the end of the catalytic domain (stick model
representation).The second half of the stretch tethering the UBA and
catalytic domain (‘‘linker,’’ w315–322) assumes an ex-
tended conformation. Remarkably, the linker has little
contact to the lobes of the catalytic domain, and in
fact L320 and adjacent residues are surrounded by in-
terstitial water (Figure 3B). Accordingly, the B factors
are high in this region (main chain B factor about 60),
but the electron density was sufficiently well defined
(Figure 3B) to trace the linker unambiguously all the
way from the end of the catalytic domain up to the
UBA domain. However, the loose attachment suggests
the possibility that the linker and UBA domain could
swing away from the catalytic domain and thus alter
the regulatory state of the domains.
Discussion
MARK kinases constitute a subfamily of the AMPK/Snf1
family of kinases within the CAMK group of Ser/Thr ki-
nases (Manning et al., 2002). Apart from a highly con-
served catalytic domain, the MARK kinases stand out
in that they contain a C-terminal KA1 domain and a
UBA domain adjacent to the catalytic domain (Figure 1).
MARK occurs in four isoforms and several splicing var-
iants. Here we present the structure of the MARK2 cata-
lytic and UBA domain, including the connecting se-
quence of amino acids with a motif that may be
involved in protein-protein recognition and regulation.
By structural comparison of MARK2 with other kinases
using the program CE (Shindyalov and Bourne, 1998),
Aurora-A and Aurora-B were consistently found at or
close to the top of the ranking, even above CHK1, which
is more closely related to MARK by sequence and which
has been used for molecular replacement. The kinase
domain of Aurora-A has been solved in an inactive
form (in complex with adenosine; PDB code 1MUO
[Cheetham et al., 2002]), as well as in active and ‘‘half-
activated’’ forms (ATPgS complexes with/without a frag-
ment of the activating protein TPX2; PDB codes 1OL5
and 1OL7, respectively [Bayliss et al., 2003]) and, thus,
lends itself as a paradigm for the discussion of the
MARK2 structure.
Activation Segment
The inactive and the fully activated form of Aurora-A
mainly differ by the conformation of the activation seg-
ment and by a 6.7º tilt of the minor lobe (Figures 4B
and 4C). In the inactive form, the activation loop is par-
tially disordered; the N and C termini of the activation
segment indicate that the activation loop points in a
direction opposite to the active conformation (to the
left side in Figure 4B), passing close below the P-loop.
In the MARK2 structures, only the C-terminal resi-
dues of the activation segment are visible. They adoptthat translates into anw30º inward rotation of the aromatic ring of tyrosine Y337. At the end of helix a2 the peptide chains bend in different di-
rections, in such a way that helix a3 ends up at almost the same position but with reversed orientation.
(C) Stereoview: details of the binding interactions between the UBA domain and the N lobe of the catalytic domain of MARK2. All three leucines at
the end of helix a3 are involved in hydrophobic interactions with the N lobe. The final leucine (L361) is also engaged in hydrophobic interactions
with helix a1, and plays an important role for the cohesion of the UBA domain. In normal UBA structures, it is the almost invariant leucine (L359 in
MARK) that is most important for the internal interactions.
(D) Stereoview: UBA domain of MARK2 overlaid with that of Dsk2p in complex with ubiquitin. The UBA domains are green (Dsk2p, PDB code
1WR1 [Ohno et al., 2005]) and purple (MARK2), ubiquitin is red, and the MARK2 kinase domain is yellow. In the overlay by least-squares fit of
ten Ca atoms of helices a1, the ubiquitin locates above the MARK2 kinase domain, with a small overlap in the b2-b3 region of the N lobe.
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180a conformation similar to the inactive form of Aurora-A,
suggesting that the activation loop of inactive MARK2
also folds to the left side (Figure 4A). By folding in this
way, cysteine residues C210 of the two monomers can
meet and form a disulfide bridge.
Superposition of MARK2 with the structure of the
phosphorylated PKA in complex with peptides derived
from protein kinase inhibitor PKI (Knighton et al., 1991;
Madhusudan et al., 2002) reveals that the C-terminal
part of the MARK2 activation loop occludes the space
required for substrate binding. Thus, in the inactive state
observed in the MARK2 structure, the substrate cannot
bind in a productive way because of steric interference
with the activation loop. Notably, threonine T208 (the
primary phosphorylation site of the activation loop) is
close to the position of the phosphorylation site (serine
S21) of the peptide substrate in the PKA complex (Ca
distance 3.5 A˚), indicating the possibility of autophos-
phorylation. In phosphorylase kinase (PHK), another ex-
ample of a kinase domain in complex with a substrate
peptide (Lowe et al., 1997), the substrate binds in an ex-
tended conformation analogous to the PKA-PKI com-
plex. As in the case of PKA, binding of the substrate to
MARK2 in the same position as in PHK would result in
a steric clash with residues 208 to 210—at least accord-
ing to the double mutant, where these residues are sta-
bilized by the disulfide bridge between cysteines C210.
Catalytic Cleft and Nucleotide Binding Site
The catalytic cleft in the MARK2 structure is extremely
wide open, compared to other active or inactive kinases.
It is 1–2 A˚ wider than the cleft of Aurora-A in the inactive
form, judged by the distance between b1 (N lobe) and b6
(C lobe). In the activated form of Aurora-A, as in other ac-
tive kinases, helix C of the N lobe contributes to nucleo-
tide binding by a conserved glutamic acid (E100 in
MARK2) that forms a salt bridge with a strictly con-
served lysine in strand b3 (K82 in MARK2; Figure 4F)
and positions this lysine for proper coordination of the
nucleotide’s a- and b-phosphates. In the crystal struc-
ture of the MARK2 double mutant, the side chains of
K82 and E100 are not aligned correctly for interaction
with the nucleotide (Figure 4D). In the wild-type struc-
ture and especially in that of the K82R mutant, the side
chains of K82 and E100 are less well ordered (by B fac-
tor) or even invisible. It is not surprising that long side
chains facing the activation loop are affected by disor-
der. This applies also to methionine M104, which reveals
a double conformation that could be identified due to
the high electron density of the selenium atom in the Se-
Met structure. There is no hint at a specific interaction
between K82 and E100 in any of the four MARK2 struc-
tures.
Conformation of the Catalytic Loop
Activation of Aurora-A involves phosphorylation of thre-
onines T287 and T288 in the activation loop. In the fully
activated state, the phospho group of pT288 (primary
phosphorylation site, corresponding to T208 in MARK2)
is engaged in ion pair interactions with R255 in the cata-
lytic loop (R174 in MARK2), adjacent to the catalytically
active aspartate D256 (D175 in MARK2; Figure 4F). This
interaction stabilizes the catalytic loop and positions
the aspartate toward the attacking OH group of the sub-strate. In MARK2, the overall fold and conformation of
the catalytic loop is the same; there are, however, signif-
icant differences that culminate at the RD motif (R174
and D175; Figures 4D–4F): the side chain of D175 is too
far from N180 further down the catalytic loop to form a
hydrogen bond, which is important for coordination of
a divalent cation. The absence of the hydrogen bond be-
tween D175 and N180 is probably a consequence of the
unusual main chain conformation of the RD motif. Possi-
bly the catalytic loop adopts several slightly different
conformations which cannot be described adequately
by a single conformation. This would agree with the
assumption that the catalytic loop needs stabilization
by interaction with the primary phospho site. The un-
usual conformation of the RD motif in MARK2 could
also be induced by interaction of the two monomers of
the dimer: helix G of one molecule protrudes toward
the catalytic loop of the other molecule, with the side
chain of N254 at the tip of helix G approaching the cata-
lytic aspartate (minimum distance 3.3 A˚; Figure 5).
C-Terminal Extension, UBA Domain, and Regulation
of MARK2
Many kinases comprise C-terminal extensions of the
catalytic core that wrap around the core domain and ter-
minate in a subdomain that binds to the N lobe. They are
probably involved in regulation of kinase activity, com-
parable to regulatory proteins of other kinases, like cy-
clins for CDKs or TPX2 and INCENP in the case of Au-
rora-A and -B, respectively. In PKA, for instance, the
C-terminal extension spirals up in a right-handed rota-
tion, and in the MAP kinases ERK2 and p38 it winds in
the opposite direction around the core domain; in either
case, the terminal subdomain ends up at a similar loca-
tion, close to helix C of the N lobe.
In MARK2, a corresponding extension consists of the
UBA domain which is linked to the catalytic domain by
a sequence of about 20 amino acids, comprising a bulge
with a cluster of negatively charged residues (wN305–
P315) and a straight section heading for the UBA domain
(linker, wP315–D322). This is roughly similar to ERK2
except that the UBA domain binds at some distance to
helix C (Figure 7). In MAP kinases, the bulge residues
(wL311–P321 in ERK2 and wF308–P318 in p38) have
been proposed as a CD domain for many upstream and
downstream interaction partners (Tanoue et al., 2000;
Tanoue and Nishida, 2003). The similarity in position,
conformation, and amino acid composition suggests
that the bulge in the structure of MARK2 may also play
a role in protein-protein recognition.
The UBA domain is linked to the potential CD domain
by a stretch of about seven residues in extended confor-
mation. As the UBA domain binds opposite to the cata-
lytic cleft, at the back of the hinge region, closure of the
catalytic cleft by rotation of the N lobe (with the UBA
domain attached on it) around the hinge would require
further elongation of the linker (e.g., by unfolding of the
CD domain) or detachment of the UBA domain from
the N lobe. Thus, it seems that the crystal structure of
MARK2 represents a state with the kinase domain
locked in an open (inactive) conformation. A similar
mechanism for regulation of kinase activity has been
proposed for Aurora-B (Sessa et al., 2005). In the crystal
structure of Aurora-B with part of the activating protein
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181INCENP, the C-terminal tail of the kinase domain as-
sumes an extended conformation and connects back
to the N lobe, similar to MARK2. In the case of Aurora-
B, the contact to the N lobe is mediated by INCENP, in
the case of MARK2 by the UBA domain. The INCENP
peptide consists of three helices that wind around the
N lobe. Interestingly, the second helix (B) binds to the
same groove at the surface of the N lobe as the UBA do-
main. Thus, in a superposition of the structures, helix B
of INCENP and helix a3 of the UBA domain would over-
lap to a large extent.
The role of the UBA domain in MARKs is unknown, but
its presence is suggestive of a ubiquitin-related func-
tion, such as protein degradation or others (Buchberger,
2002). Other possibilities include an autoregulatory role,
reminiscent of Ca/calmodulin-regulated kinases whose
C-terminal tail binds into the catalytic cleft, or members
of the PAK or MAP kinase families which have extra he-
lices that bind to the N lobe. Superposition of the
MARK2-UBA structure with published UBA-ubiquitin
complexes (Figure 6D; Ohno et al., 2005; Varadan
et al., 2005) shows an overlap between the catalytic do-
main and ubiquitin, indicating that binding of the two
would be mutually exclusive.
While the MARK sequence complies with the Prosite
profile of the UBA domain (Figure 6A; Hofmann and
Bucher, 1996), the crystal structure reveals an unex-
pected conformation as the third helix is inverted com-
pared to the known structures. It is conceivable that
the inversion of helix a3 is evoked by interaction with
the N lobe, whereas the free UBA domain (after detach-
ment from the catalytic domain) could adopt the normal
conformation. Alternatively, the unusual conformation of
the UBA domain could be a specific feature of MARK2
and related kinases. We note that the structures of
UBA domains vary considerably, complementary to
the variable interactions with mono- or polyubiquitin,
and the different linkage modes of polyubiquitin (Chim
et al., 2004). This opens a range of potential regulatory
interactions which awaits further analysis.
Experimental Procedures
Protein Preparation, Labeling, and Crystallization
Fragments of MARK2 from rat (GenBank accession number
CAB06295 [Drewes et al., 1997]) were cloned and expressed in
E. coli strain BL21 AI (Invitrogen, Karlsruhe, Germany) by using the
manufacturer’s protocol. The MARK2 fragment N39–K364 de-
scribed here was identified by limited proteolysis, and it is identical
in sequence to human MARK2. The construct includes an N-terminal
glycine (G38) left over from TEV protease cleavage of a His6 tag. All
point mutations (T208A/S212A, K82R) were subcloned from existing
plasmids and the proteins were purified as described (Timm et al.,
2003). Selenomethionine labeling was done by expression in methi-
onine auxotrophic E. coli strain B834 (Invitrogen) using M9 minimal
medium supplemented with all amino acids except methionine,
and 40 mg SeMet (Arcos Organics, Geel, Belgium) per liter. Crystals
were grown by vapor diffusion by mixing 2 ml of protein (20 mg/ml)
with 2 ml of a reservoir solution containing 7%–10% PEG 3350, 0.1
M Bis-Tris (pH 6.5), 0.2 M ammonium sulfate, or 7%–10% PEGMME
5000, 0.1 M Bis-Tris (pH 6.5), 7.5% tacsimate at room temperature.
Heavy-atom derivatives were obtained by soaking in 1 mM KAuCl4
or Yb(NO3)3. The kinase activities of the MARK2 constructs were as-
sayed as described (Drewes et al., 1997) using a substrate peptide
from the first repeat of tau containing S262 in the KXGS motif (TR1
peptide NVKSKIGSTENLK).Data Collection, Phasing, and Model Building
X-ray data were obtained at the synchrotron beamline of the X13
Consortium at DESY (Deutsches Elektronen-Synchrotron), Ham-
burg. Crystals were flash frozen and kept at 100 K in cold nitrogen.
Data reduction, statistical analysis, phasing, and refinement were
performed using programs of the HKL data processing system
V1.97.2 (Otwinowski and Minor, 1997) and the CCP4 program pack-
age (CCP4, 1994). All crystals had a similar shape (short hexagonal
rods) and belonged to space group P61; they fall, however, into
two distinct classes differing by the length of the c axis (see Table
1). The double mutant consistently crystallized in the form with the
longer c axis, whereas the wild-type crystallized in both forms,
with a preference for the shorter c axis.
A potential molecular replacement (MR) solution was obtained
with the checkpoint kinase CHK1 as a search model (PDB code
1IA8 [Chen et al., 2000]), using the program PHASER, version 1.2
(Storoni et al., 2004), which found two molecules in the asymmetric
unit. The solution was confirmed by its ability to identify heavy-atom
sites in weak Au and Yb derivatives using phases calculated from the
MR solution. Heavy-atom parameters were refined and experimen-
tal phases were calculated with MLPHARE, including the anomalous
signals of both derivatives. Occupancies of the heavy atoms ranged
between 0.27 and 0.40. Experimental phases from MLPHARE were
improved with DM by solvent flattening, histogram mapping, and
NCS averaging. The overall mean figure of merit after phase exten-
sion to 2.7 A˚ with DM was 0.79. Several rounds of manual model
building using O (Jones et al., 1991), local real space refinement
with RSRef2000 (Korostelev et al., 2002), and phase combination
of model and experimental phases were followed by automatic re-
finement with CNS 1.1 (Brunger et al., 1998) for simulated annealing,
switching to REFMAC5 (Murshudov et al., 1997) at later stages of re-
finement. At that time, higher quality crystals of the SeMet derivative
became available. This SeMet derivative was the first of four MARK2
structures to be refined to the end, using the partially refined model
of the double mutant as start model. The final R factor was 0.198
(Rfree = 0.268) using all reflections up to 2.5 A˚ (mean I/s(I) > 2). Struc-
tures of the double mutant with native methionine, wild-type, and
the K82R mutant were modeled after the SeMet derivative using the
Table 1. Data Collection and Refinement Statistics
Construct Wild-Type
T208A, S212A
Double Mutant
Space group P61 P61
Cell constants (A˚) a = b = 120.3,
c = 99.5
a = b = 119.3,
c = 105.7
Resolution range (A˚) 46.14–2.90 73.88–2.80
Data Collection
High-resolution shell (A˚) 2.95–2.90 2.85–2.80
No. of observations 122,003 132,608
No. of unique reflections 18,222 21,073
Completeness (%) 99.9 (100) 99.9 (100)
Redundancy 6.6 (6.6) 6.2 (4.8)
Rsym 0.067 (0.626) 0.102 (0.576)
<I>/<sigI> 27.8 (3.3) 17.1 (2.8)
Refinement
High-resolution shell (A˚) 2.976–2.90 2.875–2.80
No. of reflections
Working set 17,281 19,981
Test set 942 1,092
R 0.195 (0.335) 0.203 (0.313)
Rfree 0.270 (0.429) 0.262 (0.353)
No. of residues (total 654) 589 604
No. of atoms (total) 4,664 4,885
a, b, c: cell constants of the individual crystals used for data collec-
tion. Average cell constants (SD, standard deviation; n, number
of observations): Class 1 crystals: a = b = 119.58 A˚ (SD = 0.43 A˚),
c = 105.97 A˚ (SD = 0.37 A˚), n = 15. Class 2 crystals: a = b = 120.93
A˚ (SD = 0.51 A˚), c = 99.69 A˚ (SD = 0.23 A˚), n = 8. Values in parentheses
refer to high-resolution shells.
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182same subset of reflections for cross-validation. The quality of the
models was checked with the programs PROCHECK (Laskowski
et al., 1993) and WHAT_CHECK (Hooft et al., 1996) using DSSP sec-
ondary structure assignments (Kabsch and Sander, 1983).
Supplemental Data
Supplemental Data include details of experimental procedures,
crystal packing, and intermolecular contacts and can be found
with this article online at http://www.structure.org/cgi/content/full/
14/2/173/DC1/.
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